Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07177950
What this trial is testing

A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases

Who this might be right for
Breast CancerBrain MetastasesLeptomeningeal Metastasis
Peking University Cancer Hospital & Institute 51
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000
Not applicableUnknownNCT01442220
What this trial is testing

Genome-wide Association Study of Pituitary Tumors

Who this might be right for
Pituitary Adenomas
Huashan Hospital 12,500
Testing effectiveness (Phase 2)Study completedNCT02048059
What this trial is testing

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 72
Not applicableUnknownNCT05921396
What this trial is testing

Nasal Obstruction Compared by Rhinomanometry and Nasal Inspiratory Peak Flow After Endoscopic Nasal Surgery

Who this might be right for
Pituitary Adenoma InvasiveNasal Obstruction
University Hospital Ostrava 30
Not applicableLooking for participantsNCT05184790
What this trial is testing

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

Who this might be right for
Arrhythmias, CardiacBreast CancerProstatic Cancer+6 more
University of Sydney 300
Large-scale testing (Phase 3)Study completedNCT00002620
What this trial is testing

Radiation Therapy in Treating Patients With Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 212
Testing effectiveness (Phase 2)UnknownNCT01755624
What this trial is testing

Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)

Who this might be right for
1-5 Brain Metastases From Non-Small Cell Lung Cancer
NovoCure Ltd. 18
Not applicableEnded earlyNCT06315296
What this trial is testing

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Carcinoma+2 more
Thomas Jefferson University 1
Early research (Phase 1)Study completedNCT00870779
What this trial is testing

Fluorescence Guided Resection of Brain Tumors

Who this might be right for
Brain Tumors
David W. Roberts 105
Testing effectiveness (Phase 2)Study completedNCT00005859
What this trial is testing

Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 136
Large-scale testing (Phase 3)UnknownNCT00045968
What this trial is testing

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Who this might be right for
Glioblastoma MultiformeGlioblastomaGBM+4 more
Northwest Biotherapeutics 348
Early research (Phase 1)Study completedNCT00813566
What this trial is testing

Multi-Tracer PET Assessment of Primary Brain Tumors

Who this might be right for
Brain TumorsCancer
University of Utah 11
Testing effectiveness (Phase 2)Ended earlyNCT01295697
What this trial is testing

Study of EZN-2208 Pediatric Patients With Solid Tumors

Who this might be right for
Solid Tumors
Enzon Pharmaceuticals, Inc. 32
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Early research (Phase 1)Looking for participantsNCT06914479
What this trial is testing

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

Who this might be right for
Recurrent Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Malignant Brain NeoplasmResectable Brain Neoplasm
University of Michigan Rogel Cancer Center 11
Early research (Phase 1)Study completedNCT00052780
What this trial is testing

Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+22 more
National Cancer Institute (NCI) 72
Not applicableStudy completedNCT06211803
What this trial is testing

Clinical Application of the Prototype J-PET Device

Who this might be right for
Neurodegenerative DiseasesBrain NeoplasmsNeuroendocrine Tumors
Jagiellonian University 10
Early research (Phase 1)Ended earlyNCT05081180
What this trial is testing

Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

Who this might be right for
Central Nervous System Tumors
EMD Serono Research & Development Institute, Inc. 17
Early research (Phase 1)Active Not RecruitingNCT02993146
What this trial is testing

Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain
National Cancer Institute (NCI) 11
Next Page